MYXOID LIPOSARCOMA
Clinical trials for MYXOID LIPOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new MYXOID LIPOSARCOMA trials appear
Sign up with your email to follow new studies for MYXOID LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets rare sarcomas
Disease control OngoingThis early-stage study tests a new drug called BTX-A51 in 24 people with advanced liposarcoma that has spread or come back. The main goal is to check if the drug is safe and tolerable at two different doses. Researchers will also watch for any tumor shrinkage or slowing of the di…
Matched conditions: MYXOID LIPOSARCOMA
Phase: PHASE1 • Sponsor: Michael Wagner, MD • Aim: Disease control
Last updated May 17, 2026 04:00 UTC
-
Supercharged immune cells take on rare sarcomas
Disease control OngoingThis study tests a new treatment called ADP-A2M4 for people with advanced synovial sarcoma or myxoid liposarcoma that has spread or cannot be removed by surgery. The treatment uses a patient's own immune cells that are genetically modified to recognize and attack cancer cells. Th…
Matched conditions: MYXOID LIPOSARCOMA
Phase: PHASE2 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated May 17, 2026 03:55 UTC